Advertisement

Related Videos

Issues in Oncology
Cost of Care

The ASCO Post Staff

Mark J. Ratain, MD, and Daniel Goldstein, MD, on Value in Cancer Care: How the Paradigm Is Shifting

Mark J. Ratain, MD, of the University of Chicago, and Daniel Goldstein, MD, of the Rabin Medical Center, discuss the challenges of achieving cancer care value, evolution of the “more-is-better” philosophy when it comes to oncology drugs, and highlights of the First International Summit on Interventional Pharmacoeconomics.

Ian Tannock, MD, PhD, DSc, on Near-Equivalence: A Better Question Than Non-Inferiority

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

Advertisement

Advertisement




Feb
13
Today In Oncology
ASCO and Conexiant Launch ASCO AI in Oncology
Demographic and Clinicopathologic Factors in Colorectal Adenoma Recurrence Risk
ASH Publishes Clinical Guidelines on AL Amyloidosis Diagnosis
FDA Approves TTFields Device for Pancreatic Cancer
Interval Cancer Rate With AI-Supported Mammography Screening
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo